Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXD10
|
ENSG00000128710.5 | homeobox D10 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_176981076_176981274 | HOXD10 | 132 | 0.894553 | 0.78 | 1.2e-02 | Click! |
chr2_176981554_176981705 | HOXD10 | 322 | 0.731880 | 0.44 | 2.3e-01 | Click! |
chr2_176982170_176982321 | HOXD10 | 938 | 0.307652 | 0.44 | 2.3e-01 | Click! |
chr2_176981739_176981890 | HOXD10 | 507 | 0.559838 | 0.25 | 5.2e-01 | Click! |
chr2_176983652_176983803 | HOXD10 | 2420 | 0.114138 | 0.23 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr22_46477864_46478136 | 2.00 |
FLJ27365 |
hsa-mir-4763 |
1808 |
0.2 |
chr5_54456050_54456451 | 1.63 |
GPX8 |
glutathione peroxidase 8 (putative) |
252 |
0.86 |
chr11_121968787_121969071 | 1.40 |
ENSG00000207971 |
. |
1623 |
0.3 |
chr22_46462951_46463814 | 1.18 |
RP6-109B7.4 |
|
2389 |
0.16 |
chr3_114169976_114170457 | 1.13 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
3314 |
0.33 |
chr5_66254399_66254664 | 1.02 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
167 |
0.97 |
chr4_152146952_152147499 | 1.00 |
SH3D19 |
SH3 domain containing 19 |
7 |
0.98 |
chr2_197852125_197852688 | 0.98 |
ANKRD44 |
ankyrin repeat domain 44 |
12820 |
0.25 |
chr4_148944622_148945028 | 0.98 |
RP11-76G10.1 |
|
122797 |
0.06 |
chr12_78334342_78334902 | 0.94 |
NAV3 |
neuron navigator 3 |
25434 |
0.27 |
chr3_55520023_55520469 | 0.92 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
1085 |
0.48 |
chr10_70321971_70322188 | 0.91 |
TET1 |
tet methylcytosine dioxygenase 1 |
1666 |
0.36 |
chr11_69454506_69454752 | 0.91 |
CCND1 |
cyclin D1 |
1226 |
0.52 |
chr22_36232318_36232521 | 0.87 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
3846 |
0.33 |
chr6_44424385_44424803 | 0.86 |
ENSG00000266619 |
. |
21216 |
0.17 |
chr9_14312608_14313176 | 0.85 |
NFIB |
nuclear factor I/B |
774 |
0.71 |
chr6_169652381_169652976 | 0.81 |
THBS2 |
thrombospondin 2 |
432 |
0.89 |
chr12_59311038_59311457 | 0.79 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2080 |
0.36 |
chr3_150089259_150089633 | 0.78 |
TSC22D2 |
TSC22 domain family, member 2 |
36676 |
0.21 |
chr9_21688149_21688723 | 0.78 |
ENSG00000244230 |
. |
10877 |
0.24 |
chr7_116312981_116313724 | 0.78 |
MET |
met proto-oncogene |
893 |
0.68 |
chr7_114055343_114055580 | 0.77 |
FOXP2 |
forkhead box P2 |
83 |
0.98 |
chr15_93615075_93616283 | 0.76 |
RGMA |
repulsive guidance molecule family member a |
695 |
0.78 |
chr3_33318777_33319866 | 0.74 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr11_121968562_121968780 | 0.74 |
ENSG00000207971 |
. |
1881 |
0.27 |
chr3_175244326_175245006 | 0.73 |
ENSG00000201648 |
. |
82601 |
0.1 |
chr1_95330057_95330663 | 0.71 |
SLC44A3 |
solute carrier family 44, member 3 |
2527 |
0.28 |
chr4_86700210_86700446 | 0.71 |
ARHGAP24 |
Rho GTPase activating protein 24 |
469 |
0.88 |
chr15_30112674_30113382 | 0.71 |
TJP1 |
tight junction protein 1 |
723 |
0.64 |
chr4_54063057_54063462 | 0.69 |
ENSG00000207385 |
. |
68475 |
0.13 |
chr11_94528525_94528870 | 0.69 |
AMOTL1 |
angiomotin like 1 |
27160 |
0.2 |
chr2_157749235_157750071 | 0.69 |
ENSG00000263848 |
. |
122116 |
0.06 |
chr6_166259879_166260251 | 0.68 |
SDIM1 |
stress responsive DNAJB4 interacting membrane protein 1 |
49660 |
0.16 |
chr8_141733894_141734187 | 0.68 |
PTK2 |
protein tyrosine kinase 2 |
2153 |
0.35 |
chr1_215180647_215181021 | 0.68 |
KCNK2 |
potassium channel, subfamily K, member 2 |
1636 |
0.56 |
chr8_42063953_42065062 | 0.68 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr15_96884556_96884898 | 0.67 |
ENSG00000222651 |
. |
8237 |
0.16 |
chr15_35959426_35959743 | 0.64 |
DPH6 |
diphthamine biosynthesis 6 |
121191 |
0.07 |
chr7_114055046_114055222 | 0.63 |
FOXP2 |
forkhead box P2 |
21 |
0.98 |
chr9_22008020_22008450 | 0.63 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
717 |
0.61 |
chr1_185704392_185704588 | 0.63 |
HMCN1 |
hemicentin 1 |
807 |
0.75 |
chr15_99788624_99789059 | 0.63 |
TTC23 |
tetratricopeptide repeat domain 23 |
895 |
0.51 |
chr1_57041430_57041821 | 0.63 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
3616 |
0.34 |
chr6_169653692_169653887 | 0.62 |
THBS2 |
thrombospondin 2 |
350 |
0.92 |
chr6_19691587_19692480 | 0.62 |
ENSG00000200957 |
. |
49273 |
0.18 |
chr11_36252522_36252860 | 0.62 |
COMMD9 |
COMM domain containing 9 |
58283 |
0.13 |
chr1_240250348_240250507 | 0.62 |
FMN2 |
formin 2 |
4753 |
0.3 |
chr1_179111271_179111703 | 0.62 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
692 |
0.72 |
chr1_79043181_79043547 | 0.62 |
IFI44L |
interferon-induced protein 44-like |
42243 |
0.17 |
chr8_89311514_89311910 | 0.61 |
RP11-586K2.1 |
|
27353 |
0.2 |
chr5_142623144_142623555 | 0.61 |
ARHGAP26 |
Rho GTPase activating protein 26 |
36584 |
0.19 |
chr3_98700853_98701271 | 0.61 |
ENSG00000207331 |
. |
73759 |
0.1 |
chr12_91504103_91504272 | 0.61 |
LUM |
lumican |
1421 |
0.48 |
chr3_104078695_104079148 | 0.59 |
ENSG00000265076 |
. |
305281 |
0.01 |
chr8_60538222_60538702 | 0.59 |
ENSG00000201763 |
. |
170018 |
0.04 |
chr3_29327656_29328192 | 0.59 |
RBMS3-AS3 |
RBMS3 antisense RNA 3 |
4293 |
0.26 |
chr15_96882948_96883133 | 0.59 |
ENSG00000222651 |
. |
6550 |
0.16 |
chr5_32027565_32028229 | 0.59 |
ENSG00000266243 |
. |
91632 |
0.07 |
chr2_164592268_164592669 | 0.58 |
FIGN |
fidgetin |
49 |
0.99 |
chr5_167000633_167001353 | 0.58 |
CTB-78F1.1 |
|
86493 |
0.1 |
chr7_94026049_94026200 | 0.57 |
COL1A2 |
collagen, type I, alpha 2 |
2251 |
0.42 |
chr7_134464463_134465343 | 0.57 |
CALD1 |
caldesmon 1 |
474 |
0.89 |
chr6_152085810_152086045 | 0.57 |
ESR1 |
estrogen receptor 1 |
39639 |
0.18 |
chr3_150064794_150064984 | 0.57 |
TSC22D2 |
TSC22 domain family, member 2 |
61233 |
0.14 |
chr3_100785098_100785499 | 0.57 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
72939 |
0.11 |
chr4_81195528_81195918 | 0.57 |
FGF5 |
fibroblast growth factor 5 |
7930 |
0.26 |
chr9_137535305_137535456 | 0.55 |
COL5A1 |
collagen, type V, alpha 1 |
1760 |
0.38 |
chr4_160169630_160170007 | 0.55 |
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
18215 |
0.23 |
chr10_76684287_76684702 | 0.55 |
KAT6B |
K(lysine) acetyltransferase 6B |
86036 |
0.08 |
chr14_71022448_71023169 | 0.55 |
ADAM20 |
ADAM metallopeptidase domain 20 |
21076 |
0.17 |
chr2_190272115_190272296 | 0.55 |
WDR75 |
WD repeat domain 75 |
33954 |
0.2 |
chr7_134465998_134466492 | 0.55 |
CALD1 |
caldesmon 1 |
1816 |
0.49 |
chr19_47735595_47736220 | 0.55 |
BBC3 |
BCL2 binding component 3 |
116 |
0.95 |
chr7_83822850_83823057 | 0.54 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
1264 |
0.65 |
chr22_36232996_36233711 | 0.54 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
2912 |
0.37 |
chr3_21736170_21736448 | 0.54 |
ZNF385D |
zinc finger protein 385D |
56618 |
0.16 |
chr20_6764834_6765429 | 0.54 |
BMP2 |
bone morphogenetic protein 2 |
16820 |
0.28 |
chr9_89738235_89738413 | 0.53 |
C9orf170 |
chromosome 9 open reading frame 170 |
25235 |
0.26 |
chr4_121990444_121990801 | 0.53 |
NDNF |
neuron-derived neurotrophic factor |
2534 |
0.31 |
chr18_74798828_74799607 | 0.53 |
MBP |
myelin basic protein |
18000 |
0.27 |
chr6_3473109_3473260 | 0.53 |
SLC22A23 |
solute carrier family 22, member 23 |
15928 |
0.27 |
chr5_39423074_39423254 | 0.53 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
1806 |
0.48 |
chr4_159093168_159093728 | 0.53 |
RP11-597D13.9 |
|
281 |
0.64 |
chr1_99729766_99730318 | 0.52 |
LPPR4 |
Lipid phosphate phosphatase-related protein type 4 |
194 |
0.97 |
chr18_30310087_30311054 | 0.52 |
AC012123.1 |
Uncharacterized protein |
39188 |
0.17 |
chr1_8433877_8434267 | 0.52 |
RERE |
arginine-glutamic acid dipeptide (RE) repeats |
9174 |
0.19 |
chr3_114477857_114478359 | 0.52 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
10 |
0.99 |
chr11_503866_504897 | 0.51 |
RNH1 |
ribonuclease/angiogenin inhibitor 1 |
171 |
0.89 |
chr4_152148504_152148764 | 0.51 |
SH3D19 |
SH3 domain containing 19 |
548 |
0.8 |
chr12_21927918_21928225 | 0.51 |
KCNJ8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
316 |
0.88 |
chr11_12454847_12455344 | 0.51 |
PARVA |
parvin, alpha |
19187 |
0.24 |
chr18_59067267_59067515 | 0.51 |
ENSG00000206769 |
. |
8563 |
0.3 |
chr2_152214605_152215087 | 0.51 |
TNFAIP6 |
tumor necrosis factor, alpha-induced protein 6 |
740 |
0.63 |
chr17_79315981_79316442 | 0.50 |
TMEM105 |
transmembrane protein 105 |
11737 |
0.13 |
chr13_99629621_99629906 | 0.50 |
DOCK9 |
dedicator of cytokinesis 9 |
481 |
0.85 |
chr9_80437599_80437890 | 0.50 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
171 |
0.98 |
chr21_30673835_30674113 | 0.50 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
851 |
0.62 |
chr2_188418224_188418410 | 0.50 |
AC007319.1 |
|
559 |
0.57 |
chr7_94027821_94027972 | 0.50 |
COL1A2 |
collagen, type I, alpha 2 |
4023 |
0.33 |
chr4_187648403_187648661 | 0.50 |
FAT1 |
FAT atypical cadherin 1 |
656 |
0.82 |
chr6_152701109_152701260 | 0.50 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
497 |
0.78 |
chr13_39992060_39992261 | 0.49 |
ENSG00000238408 |
. |
29193 |
0.25 |
chr10_24755480_24755818 | 0.49 |
KIAA1217 |
KIAA1217 |
189 |
0.96 |
chr1_25895160_25895475 | 0.49 |
LDLRAP1 |
low density lipoprotein receptor adaptor protein 1 |
25246 |
0.17 |
chr11_121970307_121971111 | 0.49 |
ENSG00000207971 |
. |
157 |
0.79 |
chr8_142048186_142048475 | 0.49 |
PTK2 |
protein tyrosine kinase 2 |
36121 |
0.17 |
chr3_190530283_190530682 | 0.49 |
GMNC |
geminin coiled-coil domain containing |
49922 |
0.18 |
chr3_149339263_149339595 | 0.49 |
WWTR1-IT1 |
WWTR1 intronic transcript 1 (non-protein coding) |
28542 |
0.15 |
chr10_32438008_32438363 | 0.49 |
ENSG00000252482 |
. |
24427 |
0.2 |
chr4_157700840_157701063 | 0.49 |
RP11-154F14.2 |
|
61560 |
0.13 |
chr22_40707066_40707217 | 0.48 |
ADSL |
adenylosuccinate lyase |
35366 |
0.15 |
chr22_40706773_40706982 | 0.48 |
ADSL |
adenylosuccinate lyase |
35630 |
0.14 |
chr12_76653631_76654077 | 0.48 |
ENSG00000223273 |
. |
55677 |
0.14 |
chr18_53178087_53178424 | 0.48 |
TCF4 |
transcription factor 4 |
255 |
0.93 |
chr5_39418140_39418360 | 0.48 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
6720 |
0.29 |
chr13_36343879_36344030 | 0.48 |
DCLK1 |
doublecortin-like kinase 1 |
85825 |
0.1 |
chr8_122515112_122515274 | 0.48 |
ENSG00000263525 |
. |
40042 |
0.21 |
chr7_94026391_94026542 | 0.48 |
COL1A2 |
collagen, type I, alpha 2 |
2593 |
0.39 |
chr3_149801405_149801614 | 0.48 |
ENSG00000243321 |
. |
5891 |
0.21 |
chr12_59434723_59435248 | 0.48 |
RP11-150C16.1 |
|
120565 |
0.06 |
chr7_116170513_116170982 | 0.47 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
4400 |
0.18 |
chr1_1676260_1677404 | 0.47 |
SLC35E2 |
solute carrier family 35, member E2 |
526 |
0.68 |
chr5_141980216_141980760 | 0.47 |
AC005592.2 |
|
19075 |
0.18 |
chr1_196527542_196527719 | 0.47 |
ENSG00000265986 |
. |
23981 |
0.22 |
chr6_132437274_132437503 | 0.47 |
ENSG00000265669 |
. |
985 |
0.69 |
chr1_216704476_216705111 | 0.47 |
USH2A |
Usher syndrome 2A (autosomal recessive, mild) |
108055 |
0.08 |
chr5_35309735_35309886 | 0.46 |
PRLR |
prolactin receptor |
79016 |
0.1 |
chr5_78985270_78986298 | 0.46 |
CMYA5 |
cardiomyopathy associated 5 |
84 |
0.98 |
chr6_45523951_45524153 | 0.46 |
ENSG00000252738 |
. |
89789 |
0.09 |
chr12_76422565_76423423 | 0.46 |
RP11-290L1.3 |
|
1280 |
0.41 |
chr3_79023077_79023270 | 0.46 |
ENSG00000240964 |
. |
35731 |
0.2 |
chr5_102202832_102203172 | 0.46 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
1182 |
0.66 |
chr6_11795100_11795449 | 0.46 |
ADTRP |
androgen-dependent TFPI-regulating protein |
12005 |
0.28 |
chr8_32506055_32506353 | 0.46 |
NRG1 |
neuregulin 1 |
847 |
0.76 |
chr3_89074301_89074693 | 0.46 |
EPHA3 |
EPH receptor A3 |
82177 |
0.12 |
chr13_24044512_24044663 | 0.46 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
36746 |
0.21 |
chr21_28215844_28216573 | 0.45 |
ADAMTS1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
112 |
0.98 |
chr3_114168204_114168554 | 0.45 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
5151 |
0.29 |
chr6_12427440_12427701 | 0.45 |
ENSG00000223321 |
. |
20557 |
0.28 |
chr15_59622162_59622355 | 0.45 |
ENSG00000199512 |
. |
11358 |
0.14 |
chr3_109884338_109884502 | 0.45 |
ENSG00000221206 |
. |
386392 |
0.01 |
chr7_19155354_19155672 | 0.45 |
TWIST1 |
twist family bHLH transcription factor 1 |
1782 |
0.28 |
chr9_684288_685148 | 0.45 |
RP11-130C19.3 |
|
837 |
0.67 |
chr9_21677527_21678485 | 0.45 |
ENSG00000244230 |
. |
21307 |
0.21 |
chr2_202904203_202904368 | 0.45 |
FZD7 |
frizzled family receptor 7 |
4975 |
0.19 |
chr1_196622943_196623164 | 0.45 |
CFH |
complement factor H |
1867 |
0.41 |
chr6_48078606_48078757 | 0.45 |
PTCHD4 |
patched domain containing 4 |
42256 |
0.22 |
chr8_62686205_62686405 | 0.45 |
ENSG00000264408 |
. |
58958 |
0.14 |
chr1_185688405_185688780 | 0.45 |
HMCN1 |
hemicentin 1 |
15091 |
0.26 |
chr6_85484117_85484534 | 0.45 |
TBX18 |
T-box 18 |
10088 |
0.3 |
chr14_62230360_62230511 | 0.45 |
SNAPC1 |
small nuclear RNA activating complex, polypeptide 1, 43kDa |
1360 |
0.55 |
chr8_79468522_79468695 | 0.45 |
PKIA |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
34858 |
0.19 |
chr18_52626293_52626952 | 0.45 |
CCDC68 |
coiled-coil domain containing 68 |
117 |
0.97 |
chr12_29744562_29745018 | 0.44 |
TMTC1 |
transmembrane and tetratricopeptide repeat containing 1 |
12367 |
0.26 |
chr18_18775376_18775547 | 0.44 |
GREB1L |
growth regulation by estrogen in breast cancer-like |
46742 |
0.15 |
chr1_179096167_179096689 | 0.44 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
15751 |
0.19 |
chr11_85961580_85961731 | 0.44 |
EED |
embryonic ectoderm development |
5379 |
0.24 |
chr10_29922441_29923089 | 0.44 |
SVIL |
supervillin |
1136 |
0.54 |
chr3_93878024_93878443 | 0.44 |
ENSG00000253062 |
. |
60823 |
0.12 |
chr4_114679395_114679686 | 0.44 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
2684 |
0.42 |
chr1_236073367_236073780 | 0.44 |
ENSG00000206803 |
. |
5142 |
0.2 |
chr11_44383183_44383459 | 0.44 |
ALX4 |
ALX homeobox 4 |
51605 |
0.17 |
chr11_114033998_114034413 | 0.44 |
ENSG00000221112 |
. |
76554 |
0.09 |
chr22_36310772_36312004 | 0.44 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
23557 |
0.25 |
chr5_31806865_31807016 | 0.43 |
PDZD2 |
PDZ domain containing 2 |
7909 |
0.14 |
chr11_94529113_94529270 | 0.43 |
AMOTL1 |
angiomotin like 1 |
27654 |
0.2 |
chr14_71255809_71256187 | 0.43 |
MAP3K9 |
mitogen-activated protein kinase kinase kinase 9 |
5836 |
0.3 |
chr6_125550220_125550378 | 0.43 |
TPD52L1 |
tumor protein D52-like 1 |
9308 |
0.28 |
chr3_29964845_29964996 | 0.43 |
RBMS3-AS1 |
RBMS3 antisense RNA 1 |
10727 |
0.31 |
chr4_41157110_41157449 | 0.43 |
ENSG00000207198 |
. |
41320 |
0.14 |
chr4_170189368_170189538 | 0.43 |
SH3RF1 |
SH3 domain containing ring finger 1 |
1655 |
0.5 |
chr10_4719979_4720356 | 0.43 |
AKR1E2 |
aldo-keto reductase family 1, member E2 |
108654 |
0.07 |
chr8_106645652_106645917 | 0.43 |
RP11-642D21.1 |
|
36435 |
0.19 |
chr5_124071713_124071892 | 0.43 |
RP11-436H11.5 |
|
934 |
0.37 |
chr5_119802087_119802238 | 0.43 |
PRR16 |
proline rich 16 |
836 |
0.77 |
chr6_152792590_152792847 | 0.42 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
1047 |
0.59 |
chr1_94711175_94711488 | 0.42 |
ARHGAP29 |
Rho GTPase activating protein 29 |
8142 |
0.25 |
chr1_215742028_215742345 | 0.42 |
KCTD3 |
potassium channel tetramerization domain containing 3 |
1451 |
0.56 |
chr8_25864992_25865143 | 0.42 |
EBF2 |
early B-cell factor 2 |
33937 |
0.23 |
chr2_20261222_20261477 | 0.42 |
RP11-644K8.1 |
|
9454 |
0.17 |
chr4_153270968_153271263 | 0.42 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
1157 |
0.54 |
chr5_61389218_61389599 | 0.42 |
ENSG00000251983 |
. |
53084 |
0.18 |
chr15_96881380_96881711 | 0.42 |
ENSG00000222651 |
. |
5055 |
0.17 |
chr2_230845561_230845747 | 0.42 |
ENSG00000206725 |
. |
7623 |
0.17 |
chr18_46472333_46472626 | 0.42 |
SMAD7 |
SMAD family member 7 |
2396 |
0.36 |
chr6_85470567_85470756 | 0.42 |
TBX18 |
T-box 18 |
2412 |
0.42 |
chr12_64581322_64581595 | 0.42 |
ENSG00000212298 |
. |
17115 |
0.15 |
chr4_86749229_86749793 | 0.42 |
ARHGAP24 |
Rho GTPase activating protein 24 |
465 |
0.88 |
chr1_218672576_218672996 | 0.42 |
C1orf143 |
chromosome 1 open reading frame 143 |
10652 |
0.26 |
chr18_10058041_10058330 | 0.42 |
ENSG00000263630 |
. |
52991 |
0.15 |
chr12_8814882_8815352 | 0.41 |
MFAP5 |
microfibrillar associated protein 5 |
98 |
0.95 |
chr12_63025061_63025357 | 0.41 |
ENSG00000238475 |
. |
19746 |
0.14 |
chr11_89113858_89114276 | 0.41 |
NOX4 |
NADPH oxidase 4 |
109833 |
0.07 |
chr4_148009583_148009791 | 0.41 |
TTC29 |
tetratricopeptide repeat domain 29 |
142653 |
0.05 |
chr10_4358088_4358256 | 0.41 |
ENSG00000207124 |
. |
198972 |
0.03 |
chr15_60684685_60685107 | 0.41 |
ANXA2 |
annexin A2 |
1400 |
0.54 |
chr5_72417110_72417261 | 0.41 |
TMEM171 |
transmembrane protein 171 |
789 |
0.61 |
chr7_42355171_42355392 | 0.41 |
GLI3 |
GLI family zinc finger 3 |
78623 |
0.12 |
chr4_119962368_119962530 | 0.41 |
SYNPO2 |
synaptopodin 2 |
17823 |
0.26 |
chr7_151433344_151433930 | 0.41 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
237 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0031223 | auditory behavior(GO:0031223) |
0.5 | 2.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.5 | 2.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 1.6 | GO:0070141 | response to UV-A(GO:0070141) |
0.4 | 1.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 1.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.3 | 1.0 | GO:0010664 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.3 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 0.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.3 | 1.3 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.3 | 0.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.5 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 1.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.5 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.7 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.6 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 0.6 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 1.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.8 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 0.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.7 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.9 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.5 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.5 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.2 | GO:0051584 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.2 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.5 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.2 | 0.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 1.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.3 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.7 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.3 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 1.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.5 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.6 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.3 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.8 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.7 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.1 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.1 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.5 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.3 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 1.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.7 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.3 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.4 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 1.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.5 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.4 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.1 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.2 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 2.1 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:1903170 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.3 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.2 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.1 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.5 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.5 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.7 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.4 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.8 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.1 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.2 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.2 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.2 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.2 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.3 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 4.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 1.4 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.0 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.4 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.0 | GO:0072193 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0034445 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.0 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.3 | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.1 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.4 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.1 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.2 | GO:0071385 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0014044 | Schwann cell development(GO:0014044) |
0.0 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0060581 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.4 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.1 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 2.6 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.3 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0003208 | cardiac ventricle morphogenesis(GO:0003208) |
0.0 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0034331 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0009208 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.2 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.0 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) GTP metabolic process(GO:0046039) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.0 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.0 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.0 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.1 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 3.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.4 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 0.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 1.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 1.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.7 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 1.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 2.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 3.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 4.9 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 2.5 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 8.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 1.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 1.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 2.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 2.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 2.5 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.7 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 2.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.1 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.0 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 1.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 1.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 0.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 0.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 2.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.6 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 2.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 2.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.7 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 4.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 1.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 2.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 3.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 3.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 1.2 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.0 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 5.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 6.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 4.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 4.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 2.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 5.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 1.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |